Company data
Protagonist Therapeutics, Inc. employees and revenue per employee
PTGX · Biotechnology · $7.92B market cap
Protagonist Therapeutics, Inc. had 132 employees at the end of fiscal Dec 2025, up 4.8% from a year earlier. Revenue for the year was $46.0M, down 89.4% from a year earlier, or $349K per employee. Revenue fell while headcount grew.
Employees
132
+4.8% YoY
Revenue
$46.0M
-89.4% YoY
Revenue / employee
$349K
Peer median $457K
Rank in industry
71 of 110
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 132 | $46.0M | $349K | +4.8% | -89.4% |
| Dec 2024 | 126 | $434M | $3.45M | +12.5% | +624.1% |
| Dec 2023 | 112 | $60.0M | $536K | +6.7% | +125.7% |
| Dec 2022 | 105 | $26.6M | $253K | -11.0% | -2.8% |
| Dec 2021 | 118 | $27.4M | $232K | +49.4% | -4.4% |
| Dec 2020 | 79 | $28.6M | $362K | +8.2% | +12293.1% |
| Dec 2019 | 73 | $231,000 | $3K | +14.1% | -99.3% |
| Dec 2018 | 64 | $30.9M | $483K | +16.4% | +54.1% |
| Dec 2017 | 55 | $20.1M | $365K | — | — |
Open roles: we have not matched a verified job board for this company yet.
Protagonist Therapeutics, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| FENC Fennec Pharmaceuticals Inc. | 35 | $44.6M | $1.28M | Hiring into decline |
| NKTR Nektar Therapeutics | 63 | $55.2M | $877K | Hiring into decline |
| TNGX Tango Therapeutics, Inc. | 137 | $62.4M | $455K | Leaner |
| SEPN Septerna Inc | 130 | $46.0M | $353K | Efficient growth |
| PTGX Protagonist Therapeutics, Inc. | 132 | $46.0M | $349K | Hiring into decline |
| NUVB Nuvation Bio Inc. | 298 | $62.9M | $211K | Efficient growth |
| KYMR Kymera Therapeutics, Inc. | 238 | $39.2M | $165K | Hiring into decline |
| OCUL Ocular Therapeutix, Inc. | 325 | $51.8M | $159K | Hiring into decline |
| AGIO Agios Pharmaceuticals, Inc. | 539 | $54.0M | $100K | Efficient growth |
Questions about Protagonist Therapeutics, Inc.
- How many employees does Protagonist Therapeutics, Inc. have?
- Protagonist Therapeutics, Inc. reported 132 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 25, 2026. That is up 4.8% from a year earlier.
- What is Protagonist Therapeutics, Inc.'s revenue per employee?
- Protagonist Therapeutics, Inc. brought in $46.0M of revenue in fiscal Dec 2025, which is $349K per employee. That ranks 71 of 110 companies we track in Biotechnology, where the median is $457K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Outpick research
This page is the filings. The research is a membership.
On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare PTGX with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Protagonist Therapeutics, Inc.'s annual reports (Form 10-K), latest filed February 25, 2026. This is data, not a recommendation to buy or sell PTGX.